4//SEC Filing
HASTINGS DAVID C 4
Accession 0001193125-26-010361
CIK 0001563880other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:05 PM ET
Size
5.4 KB
Accession
0001193125-26-010361
Insider Transaction Report
Form 4
HASTINGS DAVID C
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
[F1]2026-01-08+375,000→ 375,000 totalExercise: $11.21Exp: 2036-01-07→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 8, 2026. The 375,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on January 8, 2027 and as to the remaining 75% of the shares in equal monthly installments thereafter through January 8, 2030.
Signature
/s/ Christopher Galletta, attorney-in-fact|2026-01-12
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001237401
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:05 PM ET
- Size
- 5.4 KB